QED Therapeutics Company
QED Therapeutics is a biotechnology company focused on precision medicine for FGFR-driven disorders.
Technology:
Personalised Medicine
Industry:
P4 Medicine
Headquarters:
Others
Founded Date:
2018-01-01
Employees Number:
11-50
Investors Number:
1
Total Funding:
$65M
Estimated Revenue:
Less than $1M
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership